|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Pneumococcal sepsis | 11.02.06.007 | 0.002924% | | Not Available |
| Clostridium difficile infection | 11.02.02.009 | - | - | Not Available |
| Mean platelet volume increased | 13.01.04.014 | 0.003655% | | Not Available |
| Oesophageal cancer metastatic | 16.13.06.003; 07.21.06.003 | 0.001462% | | Not Available |
| Breast cancer metastatic | 21.05.01.016; 16.10.01.008 | 0.013890% | | Not Available |
| Colon cancer metastatic | 16.13.01.012; 07.21.01.010 | 0.002924% | | Not Available |
| Autoimmune neutropenia | 01.02.03.013; 10.04.01.010 | 0.005605% | | Not Available |
| Infective exacerbation of chronic obstructive airways disease | 22.03.01.022; 11.01.09.015 | 0.008407% | | Not Available |
| Eosinophilic colitis | 07.08.01.019; 01.02.04.015 | 0.011210% | | Not Available |
| Bifascicular block | 02.03.01.020 | 0.005605% | | Not Available |
| Aortic dilatation | 24.03.04.007 | 0.008407% | | Not Available |
| Ovarian cancer metastatic | 21.11.01.013; 16.12.04.004 | 0.001462% | | Not Available |
| Computerised tomogram thorax abnormal | 13.19.02.005 | 0.005605% | | Not Available |
| Anticonvulsant drug level decreased | 13.17.01.024 | 0.005605% | | Not Available |
| Gastrointestinal oedema | 07.11.01.012 | 0.005605% | | Not Available |
| Troponin T increased | 13.04.01.015 | 0.072862% | | |
| Parakeratosis | 23.03.03.067 | 0.008407% | | Not Available |
| Cardiac function test abnormal | 13.14.02.006 | 0.005605% | | Not Available |
| Total cholesterol/HDL ratio increased | 13.12.01.007 | 0.001462% | | Not Available |
| Negative thoughts | 19.15.02.012 | - | - | Not Available |
| Sopor | 19.02.04.002; 17.02.04.021 | 0.140120% | | Not Available |
| Abdominal compartment syndrome | 24.04.09.009; 07.11.01.017 | 0.002924% | | Not Available |
| Psychogenic seizure | 19.24.01.007 | 0.008407% | | Not Available |
| General physical condition abnormal | 13.15.01.040 | 0.263426% | | Not Available |
| Small cell lung cancer metastatic | 22.08.01.012; 16.19.08.002 | 0.002193% | | Not Available |
| Blood alkaline phosphatase decreased | 13.04.02.003 | 0.008407% | | Not Available |
| Antipsychotic drug level above therapeutic | 13.17.01.027 | 0.145725% | | Not Available |
| Antipsychotic drug level below therapeutic | 13.17.01.028 | 0.112096% | | Not Available |
| Diabetic foot | 24.04.03.015; 23.07.03.008; 17.09.04.006; 14.07.06.001; 05.07.06.001 | 0.005605% | | Not Available |
| Catecholamines urine increased | 13.10.01.004 | 0.005605% | | Not Available |
